Status of soluble vascular cell adhesion molecule-1 in knee osteoarthritis among type 2-diabetic postmenopausal women

Reetika Shrivastava, Neelima Singh, Y. S. Chandel, R. K. S. Dhakad, Vedika Rathore, Swati Shrivastava


Background: Knee osteoarthritis is the most common form of joint disorder and a leading cause of pain and functional disability among elderly female population.  Type 2-diabetes is frequently reported comorbidity in elderly female patients with knee osteoarthritis. VCAM-1 is emerging as a strong and independent predictor for severe osteoarthritis. VCAM-1 is an inducible cell surface sialo glycoprotein and mediates heterotypic cellular aggregation. Therefore, the aim of this study is to assess the role of soluble vascular cell adhesion molecule-1 at the onset of knee osteoarthritis among type 2 diabetic postmenopausal women.

Methods: The present study includes 100 type 2-diabetic female subjects of age above 50 years as cases and 100 normal healthy female age matched individuals as controls. Osteoarthritis of knee was ascertained using the American college of rheumatology classification criteria. Serum soluble VCAM-1 concentration was measured by ELISA method in all 200 subjects. Biochemical parameters-Fasting blood sugar and lipid profile were measured using Mind ray BS-400 and HbA1c was measured by turbidimetric immunoassay method. Statistical analysis was made by student independent sample t-test. Correlation was determined by using spearman’s rank correlation coefficient.

Results: Serum level of soluble VCAM-1 was found statistically highly significant (p<0.001) in type 2 diabetic postmenopausal women having early stage of knee osteoarthritis as compared to control healthy subjects. The mean levels of fasting blood sugar, HbA1c, total cholesterol, TG, LDL-C and VLDL-C were also found significantly increased while HDL-C was found significantly decreased in cases as compared to controls.

Conclusions: The increased level of soluble VCAM-1 in type 2 diabetic subjects shows active inflammation or cartilage damage. Therefore, it can be used as an early biomarker for osteoarthritis among type 2 diabetic postmenopausal women.


Knee osteoarthritis, Type 2 diabetes Mellitus, VCAM-1

Full Text:



Arya RK, Jain V. Osteoarthritis of the knee joint: An overview. JIACM. 2013;14(2):154-62.

Akinpelu AO, Alonge TO, Adekanla BA, Odole AC. Prevalence and pattern of symptomatic knee osteoarthritis in Nigeria: A community-based study. Internet J Allied Health Sci Pract. 2009;7(3):1-7.

Davis MA, Ettinger WH, Neuhaus JM, Hauck WW. Sex differences in osteoarthritis of the knee. The role of obesity. Am J Epidemiol. 1988;127(5):1019-30.

Solomon L, Beighton P, Lawrence JS. Rheumatic disorders in the South African Negro. Patrt II. Osteo-arthrosis. S Afr Med J. 1975;49(32):1737-40.

Dasgupta D, Ray S. Menopausal Problems Among Rural and Urban Women From Eastern India. J Soc Behav Health Sci. 2009;3(1):20-33.

Dratva J, Gomez Real F, Schindler C, Ackermann-Liebrich U, Gerbase MW, Probst-Hensch NM, et al. Age at menopause increasing across Europe? Results on age at menopause and determinants from two population-based studies. Menopause. 2009;16(2):385-94.

Mahajan A, Tandon V, Verma S, Sharma S. Osteoarthritis and menopause. J Indian Rheumatol Assoc. 2005;13:21-5.

Roman-Blas JA, Castaneda S, Largo R, Herrero-Beaumon G. Osteoarthritis associated with estrogen deficiency. Arthritis Res Ther. 2009;11:241.

Crispin JC, Alcocer-Varela J. Rheumatologic manifestations of diabetes mellitus. Am J Med. 2003;114:753-7.

Arkkila PE, Gautier JF. Musculoskeletal disorders in diabetes mellitus: an update. Best Pract Res Clin Rheumatol. 2003;17:945-70.

Singh G, Miller JD, Lee FH, Pettitt D, Russell MW. Prevalence of cardiovascular disease risk factors among US adults with selfreported osteoarthritis: data from the Third National Health and Nutrition Examination Survey. Am J Manag Care. 2002;8:383-91.

Swierkot J, Guszecka-Marczynska K, Sowinsk D, Szechinski J. Rheumatic disorders in diabetes mellitus. Pol Merkur Lekarski. 2005;19:843-7.

Del Rosso A, Cerinic MM, De Giorgio F, Minari C, Rotella CM, Seghier G. Rheumatological manifestations in diabetes mellitus. Curr Diabetes Rev. 2006;4:455-66.

Douloumpakas I, Pyrpasopoulou A, Triantafyllou A, Sampanis CH, Aslanidis S. Prevalence of musculoskeletal disorders in patients with type 2 diabetes mellitus: a pilot study. Hippokratia. 2007; 4:216-8.

Burner TW, Rosenthal AK. Diabetes and rheumatic diseases. Curr Opin Rheumatol. 2009;21:50-4.

Berenbaum F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Ann Rheum Dis. 2011;70(8):1354-6.

Atayde SA, Yoshinari NH, Nascimento DP, Catanozi S, Andrade PC, Velosa AP, et al. Experimental diabetes modulates collagen remodelling of joints in rats. Histol Histopathol. 2012;27(11):1471-9.

Verzijl N, Bank RA, TeKoppele JM, DeGroot J. Ageing. Osteoarthritis: a different perspective. Curr Opin Rheumatol. 2003;15(5):616-22.

Mobasheri A. Glucose: an energy currency and structural precursor in articular cartilage and bone with emerging roles as an extracellular signaling molecule and metabolic regulator. Front Endocrinol. 2012;3:153-62.

Schett G, Kiechl S, Bonora E, Zwerina J, Mayr A, Axmann R, et al. Vascular cell adhesion molecule 1 as a predictor of severe osteoarthritis of the hip and knee joints. Arthritis Rheum. 2009;60:2381-9.

Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest. 1998;101:1905-15.

Chen NG, Holmes M, Reaven GM: Relationship between insulin resistance, soluble adhesion molecules, and mononuclear cell binding in healthy volunteers. J Clin Endocrinol Metab. 1999;84:3485-9.

MULLER WA: Mechanisms of transendothelial migration of leukocytes. Circ Res. 2009;105:223-30.

Kienzle G, Von Kempis J. Vascular cell adhesion molecule 1 (CD106) on primary human articular chondrocytes: functional regulation of expression by cytokines and comparison with intercellular adhesion molecule 1 (CD54) and very late activation antigen 2. Arthritis Rheum. 1998;41:1296-305.

Berenbaum F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Ann Rheum Dis. 2011;70:1354-6.

Cimmino MA, Cutolo M. Plasma glucose concentration in symptomatic osteoarthritis: a clinical and epidemiological survey. Clin Exp Rheumatol. 1990;8:251-7.

Rouen PA, Krein SL, Nancy E. Reame NE. Postmenopausal symptoms in female veterans with type 2 diabetes: glucose control and symptom severity. J Womens Health Larchmt. 2015;24(6):496-505.

Hart DJ, Doyle DV, Spector TD. Association between metabolic factors and knee osteoarthritis in women: the Chingford Study. J Rheumatol. 1995;22:1118-23.

Gkretsi V, Simopoulou T, Tsezou A. Lipid metabolism and osteoarthritis: lessons from atherosclerosis. Prog Lipid Res. 2011;50(2):133-40.

Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthr Cartil. 2012;20:1217-26.

Hoeven TA, Kavousi M, Ikram MA, van Meurs JB, Bindels PJ, Hofman A, et al. Markers of atherosclerosis in relation to presence and progression of knee osteoarthritis: a population-based cohort study. Rheumatol. 2015;54(9):1692-8.

Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-20.

Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang JR. AGEs interacting with their endothelial receptor induce expression of VCAM-1 in cultured human endothelial cells and in mice. J Clin Invest. 1995;96:1395-403.